US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

bioAffinity Technologies, Inc. - Common Stock (NQ:BIAF)

6.055 -0.090 (-1.46%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about bioAffinity Technologies, Inc. - Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
News headline image
bioAffinity Technologies In the News
From bioAffinity Technologies
Via Business Wire
News headline image
bioAffinity Technologies and BioVie Interviews to Air on the RedChip Small Stocks Big Money(R) Show on Bloomberg TV
Via ACCESSWIRE
News headline image
Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of Compugen Ltd. (NASDAQ: CGEN) shares rose sharply during Tuesday’s session after Gilead announced an agreement with the company to exclusively license its novel pre-clinical immunotherapy... 
Via Benzinga
News headline image
bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth Conference
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Why Cal-Maine Foods Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗
Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) jumped 95.2% to $3.7280. Gaucho Group is planning to list two of its retail properties in Argentina, in San Rafael and Cordoba, for sale, priced at $2... 
Via Benzinga
News headline image
bioAffinity Technologies Acquires Laboratory Assets of Precision Pathology Services
From bioAffinity Technologies
Via Business Wire
News headline image
bioAffinity Technologies to Participate in the H.C. Wainwright Global Investment Conference
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business Update
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
AMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung Cancer
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics Symposium
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
bioAffinity Technologies Presents Research Findings at CYTO 2023
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies Reports First Quarter 2023 Financial Results
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies Names Michael Dougherty as Chief Financial Officer
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies Presents at Cleveland Clinic Lung Cancer Symposium
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies to Ring Nasdaq Closing Bell Today
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath® Lung for Noninvasive Detection of Early-Stage Lung Cancer
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
bioAffinity Technologies to Report Fourth Quarter 2022 Financial Results on March 31, 2023
From bioAffinity Technologies, Inc.
Via Business Wire
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >